MedTrace Logo

Etonogestrel Implant and Postpartum Insertion

NCT02416687 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-04-24

No results posted yet for this study

Summary

The etonogestrel (ENG) implant inserted immediately postpartum reduces the risk of pregnancy recurrence, especially in vulnerable populations. A limitation to recommending this practice universally is the low quality of evidence on the effect of the ENG implant on breastfeeding when inserted immediately postpartum. This study is the first assessing the impact of inserting the ENG implant immediately postpartum on the amount of milk using the gold standard method for this purpose.

Conditions

  • Contraception

Interventions

DEVICE

Implanon®

Postpartum women into whom the etonogestrel-releasing contraceptive implant was inserted in the first 48 h postpartum

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Carolina S Vieira, MD, PhD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02416687 on ClinicalTrials.gov